Search results
Saxenda injections for weight loss: Side effects and benefits
The Telegraph via Yahoo News· 2 days agoInterest in the weight loss drug Saxenda has skyrocketed. According to Google Trends, searches have...
Cancer therapy trials paused after 2 deaths
Becker’s Hospital Review· 18 hours agoThe San Diego-based company has been conducting a phase 1 and two phase 2 studies on azenosertib, a drug candidate for advanced solid tumors and hematologic malignancies.
Why many people with lung cancer who have never smoked don't respond well to treatments
MedicalNewsToday via AOL· 6 days agoResearchers have honed in on two genetic mutations they say may be responsible for the...
Pediatric brain tumors rely on different metabolic | Newswise
Newswise· 6 days agoResearchers at the University of Michigan Health Rogel Cancer Center are one step closer to understanding how pediatric DIPG tumors work.
Secondary Tumors After CAR-T Cancer Therapies Are Rare: Study
US News & World Report· 6 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that the immunotherapy will create secondary cancers, a new study finds. The U.S. Food and
Scientists testing swimming 'microbots' to deliver meds to lung tumors
United Press International via Yahoo News· 4 days agoThe microbots consist of drug-filled nanoparticles attached to the surface of green algae cells,...
Study finds how lung cancer mutations may influence treatment response
Euronews via Yahoo News· 5 days agoHowever, in patients with both the EGFR and TP53 mutations, the results were more complex. While...
Zentalis' shares plunge 30% after FDA places WEE1 drug on partial hold over sepsis deaths
FierceBiotech· 13 hours agoThe FDA has placed three trials of Zentalis’ WEE1 candidate on partial hold in the wake of two...
Their cancers can't be cured. But new treatments are increasing the length, and quality, of their...
Milwaukee Journal Sentinel via Yahoo News· 6 days ago"We want to take away the guesswork to the extent possible that technology allows us, and them give...
Innovent braves bruising cytokine space, linking fusion protein to tumor responses in small study
FierceBiotech· 4 days agoIBI363 is a bispecific antibody fusion protein built on similar thinking to Bristol Myers Squibb’s doomed alliance with Nektar Therapeutics. While BMS and Nektar studied the effects of giving ...
